Astrana Health, Inc. (ASTH) Revenue Growth
Astrana Health, Inc. (ASTH) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 520.53% |
| 2018-12-31 | 45.90% |
| 2019-12-31 | 7.83% |
| 2020-12-31 | 22.58% |
| 2021-12-31 | 12.62% |
| 2022-12-31 | 47.84% |
| 2023-12-31 | 21.19% |
| 2024-12-31 | 46.72% |
| 2025-12-31 | 56.39% |
How ASTH compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| TXMD | TherapeuticsMD Inc. | 71.61% |
| AXSM | Axsome Therapeutics Inc. | 65.55% |
| IOVA | Iovance Biotherapeutics Inc. | 60.60% |
| LLY | Eli Lilly and Company | 44.70% |
| NTRA | Natera Inc. | 35.90% |
These are five companies in the same sector as ASTH with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Astrana Health, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ASTH", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ASTH | $37.96 | -1.17% | 0.37M |
| 3 | ||||
| 4 | ||||
| 5 |